Samjin Pharmaceutical Co (XKRX:005500) YoY EBITDA Growth : -13.76% (As of Mar. 2025)

View and export this data going back to 1988. Start your Free Trial

What is Samjin Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Samjin Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -13.76%.

Samjin Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2025 was ₩660.68.

Samjin Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Samjin Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samjin Pharmaceutical Co YoY EBITDA Growth Chart

Samjin Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

38.71

7.72

-15.72

-2.72

84.99

Samjin Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-8.42	98.70	45.10	-11.64	-13.76

Samjin Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Samjin Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(5227.201	-	2825.679)	/	\| 2825.679 \|
=	84.99 %

Samjin Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(660.684	-	766.124)	/	\| 766.124 \|
=	-13.76 %

Samjin Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Samjin Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Samjin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samjin Pharmaceutical Co Ltd (XKRX:005500) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

121, Wausan-ro, Mapo-Ku, Seoul, KOR, 121-837

Website

https://www.samjinpharm.co.kr

Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.

Samjin Pharmaceutical Co Headlines

No Headlines